Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (2095)	1/27/1998 11:32:00 PM
From: Dr. Voodoo	Read Replies (1) \| Respond to of 7041

Dauntless, I agree with your point, I was just pointing out the obvious. Regarding different results. I will get the workshop text soon and look it over. Even if the results were obtained using the same method, it would just distill the point that their is a disagreement with previously reported data and Zonagen's data. It means nothing,(except to Asensio and Bill)if Zonagen has conclusive proof that their method was valid and the data is valid. I know of scores of old literature references that draw erroneous conclusions based on erroneous data. Remember, I have a copy of the patent application. I am not going to speculate further on this till I see the text myself. Gosh I wish someone would answer my patent questions. I got another one--suppose I dissolved it in normal saline and drank it. Would that count?